Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia common in teens, may indicate endocrine issue, minoxidil effective treatment.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Spironolactone plus finasteride reduces hirsutism more effectively.

Androgens significantly affect female hair loss, and hormonal treatments may help.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Certain hormone treatments can improve acne and related conditions in women.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Finasteride cream reduces hair growth in women with hirsutism, but more research needed.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

Oral isotretinoin was recommended for a 21-year-old woman with severe acne.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

PCOS is a long-term condition that needs more research for better understanding and treatment.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.